Form D — Dash Bio, Inc.
0002041370-26-000003 · filed Jul 14, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Other Health Care filings
Offering
- Industry
- Other Health Care
- Exemptions
- 06b
- Reported offering amount
- $30,000,022
- Reported amount sold
- $30,000,022
- Minimum investment
- $0
- Investors
- 9
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Dash Bio, Inc.
- CIK
- 2041370
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 56 BROAD STREET
BOSTON, MA 02109 - Phone
- 617-249-4472
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
David Johnson · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Alexander Tallett · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Andy Smith · DirectorBoston, MA Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗